SPI Infoamtion

1. Plasma Market
1.1 Overview
1.2 Value-Chain of Plasma market

2. Global Blood Plasma Market
2.1 Market Size
2.2 Market Segmentation
2.2.1. IVIG or Immunoglobulin Market
2.2.1.1 Market Value
2.2.1.2 Regional Breakdown
2.2.2 Albumin
2.2.2.1 Market Value
2.2.2.2 Price Trend
2.2.2.3 Regional Breakdown
2.2.3 Clotting Factors
2.2.3.1 Market Value
2.2.3.2 Price Trend
2.2.3.3 Breakdown by Sub-segments
2.2.4 Other Plasma Derived Proteins
2.3 Supply Scenario of Plasma Market
2.3.1 Plasma Supply
2.3.2 Plasma Products Production Capacity
2.4 Industry Cost Structure

3. China Plasma Market
3.1 Market Size
3.2 Supply Scenario
3.3 Regulatory System
3.4 Competitive Scenario

4. Market Movements
4.1 Growth Drivers
4.1.1 Increasing Number of Bleeding Disorder Patients
4.1.2 Rising Aging and Total Global Population
4.1.3 Increasing Per Capita World GDP
4.1.4 U.S. National Health Expenditure
4.2 Challenges
4.2.1 Stricter Regulations
4.2.2 Ensuring Adequate Supply of Plasma
4.2.3 Recombinant Products

5. Competitive Scenario
5.1 Market Share
5.2 Investment Scenario

6. Company Profiles
6.1 Baxter
6.1.1 Business Overview
6.1.2 Business Strategies
6.1.3 Improving Gross Margins
6.1.4 Acquisitions and Investments in Businesses and Technologies
6.2 CSL Ltd
6.2.1 Business Overview
6.2.2 Business Strategies
6.2.3 Increasing Focus on Research & Development
6.2.4 Expansion Strategy
6.3 Talecris
6.3.1 Business Overview
6.3.2 Business Strategies
6.3.3 Vertical Plasma Supply Integration Strategy
6.3.4 Enhance Growth through New Plasma-Derived and Recombinant Proteins
6.4 Octapharma
6.4.1 Business Overview
6.4.2 Business Strategies
6.4.3 Production Efficiency
6.4.4 Plasma Procurement

7. Market Outlook
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis

List of Tables
Average Industrial Yields for Main Plasma Proteins
Comparison of Blood Products Utilization
Yearly Consumption of the Plasma Products per Million People
Investment strategy of Eight Major Fractionators
Dependent & Independent Variables, 2003- 2008
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output

List of Charts
Blood Constituents
Plasma Constituents
Proteins Present in Human Plasma
Value-Chain of Plasma Derived Products Market
Global Plasma-Derived Products Market, 2000-08
Global Plasma Market by Type of Proteins, 2008
Global Plasma-Derived IVIG Factors Market, 2000-2008
Geographical Break-up of Global IVIG market, 2008
Global Plasma-Derived Human Albumin Factors Market, 2000-2008
Evolution of Global Albumin Prices ($ per g), 1998-2007
Geographical Break-up of Global Albumin Market, 2008
Global Plasma-Derived Clotting Factors Market, 2000-2008
Breakdown of Global Plasma-Derived Clotting Factors Market, 2008
Global Prices of Plasma Derived Factor VIII prices, 1998-2007
Global Plasma-Derived Other Proteins Market, 2000-2008
Worldwide Origin of Plasma, 2002-2008
Plasma Collection by Geographical Area, 2006
Production Capacity of Main Fractionators (million of litres), 2008
Cost structure in Plasma Fractionation Business, 2008
Cost Structure in Pharma Business, 2008
China Plasma Product Market, 2001-2008
Regulations that Limit Raw Material Supply
Plasma Collection Volumes in China, 2003-2009E
New Drug Application (NDA) process: China SFDA Vs US FDA
Breakdown of Chinese Plasma Product Market
Number of Identified Patients (all Bleeding disorders), 1999-2008
Proportion of Old Age and Children Population, 1950-2010E
World Population, 2000-2008
Per Capita World GDP, 2003-2008
U.S. National Health Expenditure, 2000-2008
Global Plasma Fractionation Market, 2008
Plasma Collectors, 2000
Plasma Collectors, 2008
Baxter Company Revenues, 2005-2009
CSL Ltd Revenues, 2005-2009
Talecris Revenues, 2005-2009
Octapharma Revenues, 2004-2008
Global Plasma-derived Products Market Forecast, 2008-2012F